Standards of Medical Care in Diabetes: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Diabetes mellitus }} | {{Diabetes mellitus}} | ||
{{CMG}}; {{AE}} {{KGH}} | {{CMG}}; {{AE}} {{KGH}} | ||
| Line 22: | Line 21: | ||
====[[B. Management]]==== | ====[[B. Management]]==== | ||
====[[C. Glycemic control]]==== | ====[[C. Glycemic control]]==== | ||
: '''1. Assessment of glycemic control''' | |||
:* '''[[Glucose monitoring]]''' | :* '''[[Glucose monitoring]]''' | ||
:* '''[[A1C]]''' | :* '''[[A1C]]''' | ||
: '''[[2. Glycemic Goals in Adults]]''' | |||
====[[D. Pharmacological and Overall Approaches to Treatment]]==== | ====[[D. Pharmacological and Overall Approaches to Treatment]]==== | ||
: '''[[1. Insulin Therapy for Type 1 Diabetes]]''' | |||
: '''[[2. Pharmacological Therapy for Hyperglycemia in Type 2 Diabetes]]''' | |||
====[[E. Medical Nutrition Therapy (MNT)]]==== | ====[[E. Medical Nutrition Therapy (MNT)]]==== | ||
: '''General Recommendations''' | |||
:* '''Energy Balance, Overweight, and Obesity''' | :* '''Energy Balance, Overweight, and Obesity''' | ||
:* '''Recommendations for Primary Prevention of Type 2 Diabetes''' | :* '''Recommendations for Primary Prevention of Type 2 Diabetes''' | ||
| Line 40: | Line 38: | ||
:* '''Evaluation of the Diabetic Patient Before Recommending An Exercise Program''' | :* '''Evaluation of the Diabetic Patient Before Recommending An Exercise Program''' | ||
:* '''Exercise in the Presence of Nonoptimal Glycemic Control''' | :* '''Exercise in the Presence of Nonoptimal Glycemic Control''' | ||
::* | ::* ''Hyperglycemia'' | ||
::* | ::* ''Hypoglycemia'' | ||
:* '''Exercise in the presence of specific long-term complications of diabetes''' | :* '''Exercise in the presence of specific long-term complications of diabetes''' | ||
::* | ::* ''Retinopathy'' | ||
::* | ::* ''Peripheral Neuropathy'' | ||
::* | ::* ''Albuminuria and Nephropathy'' | ||
====[[Psychosocial assessment and care]]==== | ====[[Psychosocial assessment and care]]==== | ||
Revision as of 21:29, 20 December 2013
|
Diabetes mellitus Main page |
|
Patient Information |
|---|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Karol Gema Hernandez, M.D. [2]
I. Classification and Diagnosis
A. Classification
B. Diagnosis of Diabetes
C. Categories of increased risk for diabetes (prediabetes)
II. Testing for Diabetes in Asymptomatic Patients
A. Testing for Type 2 Diabetes and Risk of Future Diabetes in Adults
B. Screening for Type 2 Diabetes in Children
C. Screening for Type 1 Diabetes
III. Detection and Diagnosis Of GDM
IV. Prevention/Delay Of Type 2 Diabetes
V. Diabetes Care
A. Initial Evaluation
B. Management
C. Glycemic control
- 1. Assessment of glycemic control
- 2. Glycemic Goals in Adults
D. Pharmacological and Overall Approaches to Treatment
- 1. Insulin Therapy for Type 1 Diabetes
- 2. Pharmacological Therapy for Hyperglycemia in Type 2 Diabetes
E. Medical Nutrition Therapy (MNT)
- General Recommendations
- Energy Balance, Overweight, and Obesity
- Recommendations for Primary Prevention of Type 2 Diabetes
- Recommendations for Management of Diabetes
F. Diabetes Self-Management Education and Support
G. Physical Activity
- Frequency and Type of Exercise
- Evaluation of the Diabetic Patient Before Recommending An Exercise Program
- Exercise in the Presence of Nonoptimal Glycemic Control
- Hyperglycemia
- Hypoglycemia
- Exercise in the presence of specific long-term complications of diabetes
- Retinopathy
- Peripheral Neuropathy
- Albuminuria and Nephropathy
Psychosocial assessment and care
Hypoglycemia
Bariatric surgery
Immunization
Prevention And Management Of Diabetes Complications
CVD
Hypertension/blood pressure control
Screening and diagnosis | Goals | Treatment
Dyslipidemia/lipid management
Screening | Treatment recommendations and goals